Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Name: Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
Published: 2024
License: Public Domain

Stingray Therapeutics · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

refractory metastatic microsatellite stable colorectal cancer (mss-crc), interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Related documents